e-learning
resources
Stockholm 2007
Tuesday 18.09.2007
Community-acquired pneumonia: from aetiology to complication
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Value of hypoalbuminemia as a sign of severity of community-acquired pneumonia
F. Sanz, J. Blanquer, M. L. Briones, R. Blanquer, E. Fernández, C. Aguar, F. Tatay (Valencia, Spain)
Source:
Annual Congress 2007 - Community-acquired pneumonia: from aetiology to complication
Session:
Community-acquired pneumonia: from aetiology to complication
Session type:
Thematic Poster Session
Number:
3928
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Sanz, J. Blanquer, M. L. Briones, R. Blanquer, E. Fernández, C. Aguar, F. Tatay (Valencia, Spain). Value of hypoalbuminemia as a sign of severity of community-acquired pneumonia. Eur Respir J 2007; 30: Suppl. 51, 3928
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Severe community-acquired pneumonia
Source: Eur Respir Monogr 2016; 74: 101-116
Year: 2016
Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression
Source: Eur Respir J 2012; 40: 1201-1210
Year: 2012
Usefulness of shock index in severity assessment of community-acquired pneumonia
Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections
Year: 2007
Incidence of severe sepsis as a cause of clinical failure in patients with community-acquired pneumonia (CAP)
Source: Eur Respir J 2007; 30: Suppl. 51, 42s
Year: 2007
Clinical failure in community-acquired pneumonia
Source: International Congress 2014 – PG16 Low respiratory tract infections: learning from real clinical cases
Year: 2014
Biomarkers and severity in community-acquired pneumonia (CAP)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012
D-dimer elevation is associated with severity of community-acquired pneumonia according to CURB-65 and PSI
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006
Impact of aspiration pneumonia in community-acquired pneumonia and healthcare-associated pneumonia
Source: Annual Congress 2012 - CT findings: educational posters
Year: 2012
Etiology of severe community-acquired pneumonia in Japan
Source: Eur Respir J 2005; 26: Suppl. 49, 256s
Year: 2005
Community-acquired pneumonia (CAP): evaluation of severity criteria for hospitalization
Source: Eur Respir J 2003; 22: Suppl. 45, 335s
Year: 2003
Community-acquired pneumonia: aetiology and severity scores
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009
Biomarkers as complication predictors in community-acquired pneumonia
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Role of chest ultrasonography in prognosis of community-acquired pneumonia
Source: International Congress 2016 – A view into a chest and pleural pathology
Year: 2016
Usefullness of CPR and PCT in the etiological diagnosis of community-acquired pneumonia
Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia
Year: 2011
Procalcitonin as etiological marker of severe community-acquired pneumonia
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia
Source: Eur Respir J 2009; 34: 932-939
Year: 2009
Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
Effect of corticoids on the clinical course and outcome of severe community-acquired pneumonia
Source: Annual Congress 2004 - SARS and other lower respiratory tract infections
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept